Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹117 Cr
P/E Ratio
13.18
P/B Ratio
1.63
Industry P/E
25.02
Debt to Equity
0.13
ROE
3.38 %
ROCE
4.13 %
Div. Yield
0.26 %
Book Value
233.68
EPS
28.82
CFO
₹19.28 Cr
EBITDA
₹81.09 Cr
Net Profit
₹52.67 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Samrat Pharmachem
| -1.22 | 19.06 | 2.44 | -9.22 | -9.89 | 38.49 | 26.30 |
|
BSE Commodities
| 2.79 | 0.64 | 7.28 | 2.70 | 8.31 | 29.08 | -- |
|
BSE Small Cap
| -12.04 | 2.97 | -0.32 | 2.02 | 18.80 | 34.92 | 16.25 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Samrat Pharmachem
| 8.68 | -54.15 | 116.10 | 154.28 | 41.16 | 85.07 | -41.72 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Commodities
| 8.14 | 17.51 | 1.22 | 61.53 | 26.07 | -4.62 | -19.21 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 1,795.20 | 9,155.46 | 51.28 | 13.85 | |
| 1,855.00 | 8,037.66 | 23.09 | 26.23 | |
| 2,129.60 | 7,550.27 | 24.63 | 13.78 | |
| 2,634.00 | 8,426.66 | 10.85 | 11.45 |
No Review & Analysis are available.
Samrat Pharmachem Limited manufactures and sells pharmaceutical chemicals in India. It offers iodine salts and bromines salts, as well as iodine derivatives for industries, such as pharmaceuticals, chemicals, food, fertilizers, salt, etc. The company... also exports its products worldwide. Samrat Pharmachem Limited was founded in 1992 and is based in Mumbai, India. Read more
Incorporated
1992
Chairman
Lalit Mehta
Managing Director
Lalit Mehta
Headquarters
Ankleshwar, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Samrat Pharmachem Ltd stood at ₹ 130 Cr as on 31-Dec-24
The share price of Samrat Pharmachem Ltd is ₹378.00 (BSE) as of 28-Apr-2025 16:01 IST. Samrat Pharmachem Ltd has given a return of -9.89% in the last 3 years.
Samrat Pharmachem Ltd has a market capitalisation of ₹ 117 Cr as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Samrat Pharmachem Ltd is 1.63 times as on 28-Apr-2025, a 29% discount to its peers’ median range of 2.30 times.
The P/E ratio of Samrat Pharmachem Ltd is 13.18 times as on 28-Apr-2025, a 47% discount to its peers’ median range of 25.02 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Samrat Pharmachem Ltd and enter the required number of quantities and click on buy to purchase the shares of Samrat Pharmachem Ltd.
Samrat Pharmachem Limited manufactures and sells pharmaceutical chemicals in India. It offers iodine salts and bromines salts, as well as iodine derivatives for industries, such as pharmaceuticals, chemicals, food, fertilizers, salt, etc. The company also exports its products worldwide. Samrat Pharmachem Limited was founded in 1992 and is based in Mumbai, India.
The prominent promoters of Samrat Pharmachem Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Lalit Damodar Mehta |
13.97%
|
|
Rajesh Lalit Mehta |
12.41%
|
|
Premal Lalit Mehta |
5.67%
|
|
Kaushal Lalit Mehta |
4.5%
|
|
Jaya Lalit Mehta |
3.86%
|
The chairman of the company is Lalit Mehta, and the managing director is Lalit Mehta.
There is no promoter pledging in Samrat Pharmachem Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,239
|
|
|
8,289
|
|
|
7,921
|
|
|
7,669
|
| Samrat Pharmachem Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
13.25
|
|
Operating margin(%)
|
3.64
|
|
Net Margin(%)
|
2.98
|
|
Dividend yield(%)
|
0.27
|
Yes, TTM profit after tax of Samrat Pharmachem Ltd was ₹9 Cr.
₹1.50
(
